Skip to main content
Erschienen in: International Ophthalmology 3/2017

01.08.2016 | Original Paper

Activation of toxoplasma retinochoroiditis during pregnancy and evaluation of ocular findings in newborns

verfasst von: Fatih Mehmet Türkcü, Alparslan Şahin, Harun Yüksel, Yasin Çınar, Kürşat Cingü, Suat Altındağ, Özcan Deveci, Zeynep Özkurt, İhsan Çaça

Erschienen in: International Ophthalmology | Ausgabe 3/2017

Einloggen, um Zugang zu erhalten

Abstract

The purpose of this study was to evaluate patients with activation of toxoplasma retinochoroiditis during pregnancy and ocular findings in newborns. A total of 17 pregnant patients who were clinically and serologically diagnosed with ocular toxoplasmosis were retrospectively reviewed. After birth, ocular findings for all infants were recorded. The mean age of the patients was 29.08 ± 5.71 years. In all cases, activation was present in only one eye. In 13 cases, anterior uveitis was associated with posterior uveitis. Visual acuity in all cases prior to treatment was 0.3 ± 0.21 and increased to 0.55 ± 0.29 after treatment. The mean gestational age of the patients was 19.76 ± 8.71 weeks at the time of hospital admission. No case of toxoplasmic ocular involvement was identified in the infants on postnatal examination. In the case of toxoplasma retinochoroiditis during pregnancy, appropriate treatment and follow-up is very important to protect the newborns and to prevent impaired vision in mothers.
Literatur
1.
Zurück zum Zitat Türkcü FM, Yüksel H, Cingü AK, Çınar Y, Şahin M, Özkurt Z, Murat M, Şahin A, Çaça İ (2013) Demographic and etiologic features of adult patients with uveitis in southeastern Anatolia. Dicle Med J 40:605–610CrossRef Türkcü FM, Yüksel H, Cingü AK, Çınar Y, Şahin M, Özkurt Z, Murat M, Şahin A, Çaça İ (2013) Demographic and etiologic features of adult patients with uveitis in southeastern Anatolia. Dicle Med J 40:605–610CrossRef
2.
Zurück zum Zitat Tugal-Tutkun I, Corum I, Otuk B, Urgancioglu M (2005) Active ocular toxoplasmosis in Turkish patients: a report on 109 cases. Int Ophthalmol 26:221–228CrossRefPubMed Tugal-Tutkun I, Corum I, Otuk B, Urgancioglu M (2005) Active ocular toxoplasmosis in Turkish patients: a report on 109 cases. Int Ophthalmol 26:221–228CrossRefPubMed
3.
Zurück zum Zitat de-la-Torre A, Lopez-Castillo CA, Rueda JC, Mantilla RD, Gómez-Marín JE, Anaya JM (2009) Clinical patterns of uveitis in two ophthalmology centres in Bogota, Colombia. Clin Exp Ophthalmol 37:458–466CrossRefPubMed de-la-Torre A, Lopez-Castillo CA, Rueda JC, Mantilla RD, Gómez-Marín JE, Anaya JM (2009) Clinical patterns of uveitis in two ophthalmology centres in Bogota, Colombia. Clin Exp Ophthalmol 37:458–466CrossRefPubMed
4.
Zurück zum Zitat Garweg JG, Scherrer J, Wallon M, Kodjikian L, Peyron F (2005) Reactivation of ocular toxoplasmosis during pregnancy. BJOG 112:241–242CrossRefPubMed Garweg JG, Scherrer J, Wallon M, Kodjikian L, Peyron F (2005) Reactivation of ocular toxoplasmosis during pregnancy. BJOG 112:241–242CrossRefPubMed
5.
Zurück zum Zitat Petersen E, Kijlstra A, Stanford M (2012) Epidemiology of ocular toxoplasmosis. Ocul Immunol Inflamm 20:68–75CrossRefPubMed Petersen E, Kijlstra A, Stanford M (2012) Epidemiology of ocular toxoplasmosis. Ocul Immunol Inflamm 20:68–75CrossRefPubMed
6.
7.
Zurück zum Zitat McAuley J, Boyer KM, Patel D, Mets M, Swisher C, Roizen N, Wolters C, Stein L, Stein M, Schey W et al (1994) Early and longitudinal evaluations of treated infants and children and untreated historical patients with congenital toxoplasmosis: the Chicago Collaborative Treatment Trial. Clin Infect Dis 18:38–72CrossRefPubMed McAuley J, Boyer KM, Patel D, Mets M, Swisher C, Roizen N, Wolters C, Stein L, Stein M, Schey W et al (1994) Early and longitudinal evaluations of treated infants and children and untreated historical patients with congenital toxoplasmosis: the Chicago Collaborative Treatment Trial. Clin Infect Dis 18:38–72CrossRefPubMed
8.
Zurück zum Zitat Berrébi A, Assouline C, Bessières MH, Lathière M, Cassaing S, Minville V, Ayoubi JM (2010) Long-term outcome of children with congenital toxoplasmosis. Am J Obstet Gynecol 203:552CrossRefPubMed Berrébi A, Assouline C, Bessières MH, Lathière M, Cassaing S, Minville V, Ayoubi JM (2010) Long-term outcome of children with congenital toxoplasmosis. Am J Obstet Gynecol 203:552CrossRefPubMed
9.
Zurück zum Zitat Wilson CB, Remington JS, Stagno S, Reynolds DW (1980) Development of adverse sequelae in children born with subclinical congenital toxoplasma infection. Pediatrics 66:767–774PubMed Wilson CB, Remington JS, Stagno S, Reynolds DW (1980) Development of adverse sequelae in children born with subclinical congenital toxoplasma infection. Pediatrics 66:767–774PubMed
10.
Zurück zum Zitat Silveira C, Ferreira R, Muccioli C, Nussenblatt R, Belfort R Jr (2003) Toxoplasmosis transmitted to a newborn from the mother infected 20 years earlier. Am J Ophthalmol 136:370–371CrossRefPubMed Silveira C, Ferreira R, Muccioli C, Nussenblatt R, Belfort R Jr (2003) Toxoplasmosis transmitted to a newborn from the mother infected 20 years earlier. Am J Ophthalmol 136:370–371CrossRefPubMed
11.
Zurück zum Zitat Ertug S, Okyay P, Turkmen M, Yuksel H (2005) Seroprevalence and risk factors for toxoplasma infection among pregnant women in Aydin province, Turkey. BMC Public Health 15:66CrossRef Ertug S, Okyay P, Turkmen M, Yuksel H (2005) Seroprevalence and risk factors for toxoplasma infection among pregnant women in Aydin province, Turkey. BMC Public Health 15:66CrossRef
12.
Zurück zum Zitat Kump LI, Androudi SN, Foster CS (2005) Ocular toxoplasmosis in pregnancy. Clin Exp Ophthalmol 33:455–460CrossRefPubMed Kump LI, Androudi SN, Foster CS (2005) Ocular toxoplasmosis in pregnancy. Clin Exp Ophthalmol 33:455–460CrossRefPubMed
13.
Zurück zum Zitat Harma M, Harma M, Gungen N, Demir N (2004) Toxoplasmosis in pregnant women in Sanliurfa, Southeastern Anatolia City, Turkey. J Egypt Soc Parasitol 34:519–525PubMed Harma M, Harma M, Gungen N, Demir N (2004) Toxoplasmosis in pregnant women in Sanliurfa, Southeastern Anatolia City, Turkey. J Egypt Soc Parasitol 34:519–525PubMed
14.
Zurück zum Zitat Ocak S, Zeteroglu S, Ozer C, Dolapcioglu K, Gungoren A (2007) Seroprevalence of Toxoplasma gondii, rubella and cytomegalovirus among pregnant women in southern Turkey. Scand J Infect Dis 39:231–234 Ocak S, Zeteroglu S, Ozer C, Dolapcioglu K, Gungoren A (2007) Seroprevalence of Toxoplasma gondii, rubella and cytomegalovirus among pregnant women in southern Turkey. Scand J Infect Dis 39:231–234
15.
Zurück zum Zitat Braakenburg AM, Rothova A (2009) Clinical features of ocular toxoplasmosis during pregnancy. Retina 29:627–630CrossRefPubMed Braakenburg AM, Rothova A (2009) Clinical features of ocular toxoplasmosis during pregnancy. Retina 29:627–630CrossRefPubMed
16.
Zurück zum Zitat Friedmann CT, Knox DL (1969) Variations in recurrent active toxoplasmic retinochoroiditis. Arch Ophthalmol 81:481–493CrossRefPubMed Friedmann CT, Knox DL (1969) Variations in recurrent active toxoplasmic retinochoroiditis. Arch Ophthalmol 81:481–493CrossRefPubMed
17.
Zurück zum Zitat O’Connor GR (1983) Factors related to the initiation and recurrence of uveitis. XL Edward Jackson memorial lecture. Am J Ophthalmol 96:577–599CrossRefPubMed O’Connor GR (1983) Factors related to the initiation and recurrence of uveitis. XL Edward Jackson memorial lecture. Am J Ophthalmol 96:577–599CrossRefPubMed
18.
Zurück zum Zitat Chan CC, Reed GF, Kim Y, Agrón E, Buggage RR (2004) A correlation of pregnancy term, disease activity, serum female hormones, and cytokines in uveitis. Br J Ophthalmol 88:1506–1509CrossRefPubMedPubMedCentral Chan CC, Reed GF, Kim Y, Agrón E, Buggage RR (2004) A correlation of pregnancy term, disease activity, serum female hormones, and cytokines in uveitis. Br J Ophthalmol 88:1506–1509CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat Reich M, Ruppenstein M, Becker MD, Mackensen F (2014) Risk of recurrence of preexisting ocular toxoplasmosis during pregnancy. Ocul Immunol Inflamm 9:1–6 Reich M, Ruppenstein M, Becker MD, Mackensen F (2014) Risk of recurrence of preexisting ocular toxoplasmosis during pregnancy. Ocul Immunol Inflamm 9:1–6
20.
Zurück zum Zitat Holland GN (1989) Ocular toxoplasmosis in the immunocompromised host. Int Ophthalmol 13:399–402CrossRefPubMed Holland GN (1989) Ocular toxoplasmosis in the immunocompromised host. Int Ophthalmol 13:399–402CrossRefPubMed
21.
Zurück zum Zitat Dunn D, Wallon M, Peyron F, Petersen E, Peckham C, Gilbert R (1999) Mother-to-child transmission of toxoplasmosis: risk estimates for clinical counselling. Lancet 353:1829–1833CrossRefPubMed Dunn D, Wallon M, Peyron F, Petersen E, Peckham C, Gilbert R (1999) Mother-to-child transmission of toxoplasmosis: risk estimates for clinical counselling. Lancet 353:1829–1833CrossRefPubMed
22.
Zurück zum Zitat Montoya JG, Kovacs JA, Remington JS (2005) Toxoplasma gondii. In: Mandell GL, Bennett JE, Dolin R (eds) Principles and pratice of infectious disease, 6th edn. Elsevier Churchill Livingstone, Philedelphia, pp 3170–3198 Montoya JG, Kovacs JA, Remington JS (2005) Toxoplasma gondii. In: Mandell GL, Bennett JE, Dolin R (eds) Principles and pratice of infectious disease, 6th edn. Elsevier Churchill Livingstone, Philedelphia, pp 3170–3198
23.
Zurück zum Zitat Bosch-Driessen LH, Karimi S, Stilma JS, Rothova A (2000) Retinal detachment in ocular toxoplasmosis. Ophthalmology 107:36–40CrossRefPubMed Bosch-Driessen LH, Karimi S, Stilma JS, Rothova A (2000) Retinal detachment in ocular toxoplasmosis. Ophthalmology 107:36–40CrossRefPubMed
24.
Zurück zum Zitat Engstrom RE, Holland GN, Nussenblatt RB, Jabs DA (1991) Current practices in the management of ocular toxoplasmosis. Am J Ophthalmol 111:601–610CrossRefPubMed Engstrom RE, Holland GN, Nussenblatt RB, Jabs DA (1991) Current practices in the management of ocular toxoplasmosis. Am J Ophthalmol 111:601–610CrossRefPubMed
25.
Zurück zum Zitat Delair E, Monnet D, Grabar S, Dupouy-Camet J, Yera H, Brézin AP (2008) Respective roles of acquired and congenital infections in presumed ocular toxoplasmosis. Am J Ophthalmol 146:851–855CrossRefPubMed Delair E, Monnet D, Grabar S, Dupouy-Camet J, Yera H, Brézin AP (2008) Respective roles of acquired and congenital infections in presumed ocular toxoplasmosis. Am J Ophthalmol 146:851–855CrossRefPubMed
26.
Zurück zum Zitat Kodjikian L, Wallon M, Fleury J, Denis P, Binquet C, Peyron F, Garweg JG (2006) Ocular manifestations in congenital toxoplasmosis. Graefes Arch Clin Exp Ophthalmol 244:14–21CrossRefPubMed Kodjikian L, Wallon M, Fleury J, Denis P, Binquet C, Peyron F, Garweg JG (2006) Ocular manifestations in congenital toxoplasmosis. Graefes Arch Clin Exp Ophthalmol 244:14–21CrossRefPubMed
27.
Zurück zum Zitat Martinez CE, Zhang D, Conway MD, Peyman GA (1998) Successful management of ocular toxoplasmosis during pregnancy using combined intraocular clindamycin and dexamethasone with systemic sulfadiazine. Int Ophthalmol 22:85–88CrossRefPubMed Martinez CE, Zhang D, Conway MD, Peyman GA (1998) Successful management of ocular toxoplasmosis during pregnancy using combined intraocular clindamycin and dexamethasone with systemic sulfadiazine. Int Ophthalmol 22:85–88CrossRefPubMed
28.
Zurück zum Zitat de Jong PT (1989) Congenital toxoplasmosis: common and rare symptomsand signs. Int Ophthalmol 13:391–397CrossRefPubMed de Jong PT (1989) Congenital toxoplasmosis: common and rare symptomsand signs. Int Ophthalmol 13:391–397CrossRefPubMed
Metadaten
Titel
Activation of toxoplasma retinochoroiditis during pregnancy and evaluation of ocular findings in newborns
verfasst von
Fatih Mehmet Türkcü
Alparslan Şahin
Harun Yüksel
Yasin Çınar
Kürşat Cingü
Suat Altındağ
Özcan Deveci
Zeynep Özkurt
İhsan Çaça
Publikationsdatum
01.08.2016
Verlag
Springer Netherlands
Erschienen in
International Ophthalmology / Ausgabe 3/2017
Print ISSN: 0165-5701
Elektronische ISSN: 1573-2630
DOI
https://doi.org/10.1007/s10792-016-0311-7

Weitere Artikel der Ausgabe 3/2017

International Ophthalmology 3/2017 Zur Ausgabe

Neu im Fachgebiet Augenheilkunde

Metastase in der periokulären Region

Metastasen Leitthema

Orbitale und periokuläre metastatische Tumoren galten früher als sehr selten. Aber mit der ständigen Aktualisierung von Medikamenten und Nachweismethoden für die Krebsbehandlung werden neue Chemotherapien und Strahlenbehandlungen eingesetzt. Die …

Staging und Systemtherapie bei okulären und periokulären Metastasen

Metastasen Leitthema

Metastasen bösartiger Erkrankungen sind die häufigsten Tumoren, die im Auge diagnostiziert werden. Sie treten bei ungefähr 5–10 % der Patienten mit soliden Tumoren im Verlauf der Erkrankung auf. Besonders häufig sind diese beim Mammakarzinom und …

Wundheilung nach Trabekulektomie

Trabekulektomie CME-Artikel

Die überschießende Wundheilung in der filtrierenden Glaukomchirurgie ist ein zentraler Faktor für ein operatives Versagen. Nach der Einführung der Trabekulektomie in den 1960er-Jahren wurden viele Faktoren erkannt, die mit einer vermehrten …

„standard operating procedures“ (SOP) – Vorschlag zum therapeutischen Management bei periokulären sowie intraokulären Metastasen

Metastasen Leitthema

Peri- sowie intraokuläre Metastasen sind insgesamt gesehen selten und meist Zeichen einer fortgeschrittenen primären Tumorerkrankung. Die Therapie ist daher zumeist palliativ und selten kurativ. Zudem ist die Therapiefindung sehr individuell. Die …

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.